Edwards acquires Baxter JV
This article was originally published in The Gray Sheet
Executive Summary
Japanese cardiovascular business purchase for $22 mil. will contribute to the firm's growing global presence, Edwards says Oct. 1. The purchase price excludes $30 mil. in receivable securitized accounts. The business unit, operating as a joint venture with Baxter International, generated sales of $170 mil. in 2001. Edwards Lifesciences will record approximately $3 mil. in one-time expenses from the acquisition in the third quarter...